Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Dose Response in Knee Osteoarthritis
NCT05330689Phase 2Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
A Phase 2 trial of platelet-rich plasma in osteoarthritis (OA), sponsored by Vanderbilt University Medical Center. Planned start Mar 2022; status: withdrawn.
02
Drugs
platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05330689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05330689.